RAM
LEGN icon

Readystate Asset Management’s Legend Biotech LEGN Stock Holding History

Readystate Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-178,012
Closed -$6.32M – 541
2025
Q2 		$6.32M Buy
178,012
+643
+0.4% +$20.8K 0.19% 95
2025
Q1 		$6.02M Buy
+177,369
New +$6.36M 0.2% 82

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Readystate Asset Management's LEGN Position: Q3 2025 in Review

Readystate Asset Management sold out of Legend Biotech (LEGN) in Q3 2025, closing a stake of 178,012 shares — an estimated $6.32M sold.

Readystate Asset Management first reported a position in LEGN in Q1 2025 and held it in 2 quarters. The position peaked at $6.32M in Q2 2025. 199 funds tracked by Wall St. Rank hold LEGN as of Q3 2025.

  • Readystate Asset Management reported no remaining Legend Biotech position as of Q3 2025 after selling out during the quarter.
  • Readystate Asset Management sold 178,012 Legend Biotech shares in Q3 2025, an estimated $6.32M.
  • Readystate Asset Management first reported a position in Legend Biotech in Q1 2025 and held it in 2 quarters.
  • Readystate Asset Management's Legend Biotech position peaked at $6.32M in Q2 2025.
  • 199 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2025.

Based on Readystate Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.